Shares of Ritter Pharmaceuticals Inc (NASDAQ:RTTR) saw strong trading volume on Wednesday . 9,364,683 shares changed hands during trading, an increase of 3% from the previous session’s volume of 9,048,219 shares.The stock last traded at $0.22 and had previously closed at $0.19.
Separately, ValuEngine upgraded Ritter Pharmaceuticals from a “sell” rating to a “hold” rating in a research note on Monday, September 30th.
The company has a 50 day moving average price of $0.19 and a 200-day moving average price of $0.52.
Ritter Pharmaceuticals Company Profile (NASDAQ:RTTR)
Ritter Pharmaceuticals, Inc develops and sells novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases. Its lead product candidate is RP-G28, a novel microbiome modulator, which has completed Phase 2b clinical trial for the reduction of symptoms associated with lactose intolerance.
Further Reading: How to calculate compound interest
Receive News & Ratings for Ritter Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ritter Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.